Measuring Activity in the Ubiquitin–Proteasome System: From Large Scale Discoveries to Single Cells Analysis

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cell Biochemistry and Biophysics

• Publication date

  2013-05-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12013-013-9621-9PMID 23686610PMCID PMC3758771
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p53 mutations in cancer

  2013cited by this paper
• An improved short‐lived fluorescent protein transcriptional reporter for Saccharomyces cerevisiae

  2012cited by this paper
• Metabolism of peptide reporters in cell lysates and single cells.

  2012cited by this paper
• Intra-tumour heterogeneity: a looking glass for cancer?

  2012cited by this paper
• One-shot NMR analysis of microbial secretions identifies highly potent proteasome inhibitor

  2012cited by this paper
• Fluorescence-based sensors to monitor localization and functions of linear and K63-linked ubiquitin chains in cells.

  2012cited by this paper
• Ubiquitin chain conformation regulates recognition and activity of interacting proteins

  2012cited by this paper
• A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance.

  2012cited by this paper
• Polyubiquitin-sensor proteins reveal localization and linkage-type dependence of cellular ubiquitin signaling

  2012cited by this paper
• In vivo imaging of proteasome inhibition using a proteasome‐sensitive fluorescent reporter

  2012cited by this paper
• Measuring rates of ubiquitin chain formation as a functional readout of ligase activity.

  2012cited by this paper
• Proline-mediated Proteasomal Degradation of the Prostate-specific Tumor Suppressor NKX3.1*

  2012cited by this paper
• Sequence- and species-dependence of proteasomal processivity.

  2012cited by this paper
• Development of a peptidase-resistant substrate for single-cell measurement of protein kinase B activation.

  2012cited by this paper
• Function and regulation of SUMO proteases

  2012cited by this paper
• The size of the proteasomal substrate determines whether its degradation will be mediated by mono- or polyubiquitylation.

  2012cited by this paper
• The C-terminal Proteolytic Fragment of the Breast Cancer Susceptibility Type 1 Protein (BRCA1) Is Degraded by the N-end Rule Pathway*

  2012cited by this paper
• Patient-derived tumour xenografts as models for oncology drug development

  2012cited by this paper
• Poly-Small Ubiquitin-like Modifier (PolySUMO)-binding Proteins Identified through a String Search*

  2012cited by this paper
• Ubiquitin Ligase Substrate Identification through Quantitative Proteomics at Both the Protein and Peptide Levels

  2011cited by this paper
• The N-end rule pathway: emerging functions and molecular principles of substrate recognition

  2011cited by this paper
• Dependence of Proteasome Processing Rate on Substrate Unfolding*

  2011cited by this paper
• Single-cell analysis of phosphoinositide 3-kinase and phosphatase and tensin homolog activation.

  2011cited by this paper
• Protein standard absolute quantification (PSAQ) method for the measurement of cellular ubiquitin pools

  2011cited by this paper
• Global identification of modular cullin-RING ligase substrates.

  2011cited by this paper
• A Cell-Based High-Throughput Assay for the Screening of Small-Molecule Inhibitors of p53–MDM2 Interaction

  2011cited by this paper
• Single-Cell Analysis of Phosphoinositide 3-Kinase (PI3K) and Phosphatase and Tensin Homolog (PTEN) Activation

  2011cited by this paper
• E3 Ligases Determine Ubiquitination Site and Conjugate Type by Enforcing Specificity on E2 Enzymes*

  2011cited by this paper
• Small-Molecule Hydrophobic Tagging Induced Degradation of HaloTag Fusion Proteins

  2011cited by this paper
• A Screenable in vivo Assay to Study Proteostasis Networks in Caenorhabditis elegans

  2011cited by this paper
• The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation

  2011cited by this paper
• The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation

  2011cited by this paper
• The spatial and temporal organization of ubiquitin networks

  2011cited by this paper
• Proteasomal degradation from internal sites favors partial proteolysis via remote domain stabilization.

  2011cited by this paper
• Measuring enzyme activity in single cells.

  2011cited by this paper
• Small molecule displacement of a cryptic degron causes conditional protein degradation

  2011cited by this paper
• Constructing and decoding unconventional ubiquitin chains

  2011cited by this paper
• Proteasomes and protein conjugation across domains of life

  2011cited by this paper
• Characterization of Selective Ubiquitin and Ubiquitin-Like Protease Inhibitors Using a Fluorescence-Based Multiplex Assay Format

  2011cited by this paper
• Defining the geometry of the two-component proteasome degron

  2011cited by this paper
• Systematic and quantitative assessment of the ubiquitin-modified proteome.

  2011cited by this paper
• Synthetic biology approach to reconstituting the ubiquitylation cascade in bacteria

  2011cited by this paper
• Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review

  2010cited by this paper
• Prokaryotic Ubiquitin-Like Protein Provides a Two-Part Degron to Mycobacterium Proteasome Substrates

  2010cited by this paper
• A photoconvertible reporter of the ubiquitin-proteasome system in vivo

  2010cited by this paper
• Corrigendum: A photoconvertible reporter of the ubiquitin-proteasome system in vivo

  2010cited by this paper
• Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit

  2010cited by this paper
• A new fluorogenic peptide determines proteasome activity in single cells.

  2010cited by this paper
• Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit

  2010cited by this paper
• DUBs and cancer: The role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors

  2009cited by this paper
• Development and optimization of a cell‐based assay for the selection of synthetic compounds that potentiate bone morphogenetic protein‐2 activity

  2009cited by this paper
• A simple and high-sensitivity method for analysis of ubiquitination and polyubiquitination based on wheat cell-free protein synthesis

  2009cited by this paper
• The Ubiquitin-Proteasome Reporter GFPu Does Not Accumulate in Neurons of the R6/2 Transgenic Mouse Model of Huntington's Disease

  2009cited by this paper
• Aging Is Not Associated with Proteasome Impairment in UPS Reporter Mice

  2009cited by this paper
• Detection of Sequential Polyubiquitylation on a Millisecond Time-Scale

  2009cited by this paper
• A Cellular Model To Monitor Proteasome Dysfunction by α-Synuclein

  2009cited by this paper
• Detection and characterization of SUMO protease activity using a sensitive enzyme-based reporter assay.

  2009cited by this paper
• Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin‐binding entities

  2009cited by this paper
• Targeting proteins for degradation.

  2009cited by this paper
• Large-scale detection of ubiquitination substrates using cell extracts and protein microarrays

  2009cited by this paper
• RING domain E3 ubiquitin ligases.

  2009cited by this paper
• Cell-based bioluminescent assays for all three proteasome activities in a homogeneous format.

  2009cited by this paper
• Diversity of degradation signals in the ubiquitin–proteasome system

  2008cited by this paper
• Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities

  2008cited by this paper
• Substrate-binding Sites of UBR1, the Ubiquitin Ligase of the N-end Rule Pathway*

  2008cited by this paper
• High-Throughput Bioluminescence Screening of Ubiquitin-Proteasome Pathway Inhibitors from Chemical and Natural Sources

  2007cited by this paper
• Proteasome inhibitor, bortezomib, for myeloma and lymphoma

  2007cited by this paper
• A High-Throughput Screen Measuring Ubiquitination of p53 by Human mdm2

  2007cited by this paper
• A fluorescence-resonance-energy-transfer-based protease activity assay and its use to monitor paralog-specific small ubiquitin-like modifier processing.

  2007cited by this paper
• Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes.

  2007cited by this paper
• Proteasome substrate degradation requires association plus extended peptide

  2007cited by this paper
• Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib.

  2006cited by this paper
• Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib

  2005cited by this paper
• Monitoring of ubiquitin-dependent proteolysis with green fluorescent protein substrates.

  2005cited by this paper
• Probing the ubiquitin/proteasome system with ornithine decarboxylase, a ubiquitin-independent substrate.

  2005cited by this paper
• Application and analysis of the GFPu family of ubiquitin-proteasome system reporters.

  2005cited by this paper
• A homogeneous FRET assay system for multiubiquitin chain assembly and disassembly.

  2005cited by this paper
• Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates.

  2005cited by this paper
• Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma.

  2005cited by this paper
• Spying on cancer: molecular imaging in vivo with genetically encoded reporters.

  2005cited by this paper
• An unstructured initiation site is required for efficient proteasome-mediated degradation

  2004cited by this paper
• Assay for Ubiquitin Ligase Activity: High-Throughput Screen for Inhibitors of HDM2

  2004cited by this paper
• Real-time monitoring of ubiquitination in living cells by BRET

  2004cited by this paper
• Structure of a -TrCP1-Skp1--Catenin Complex

  2003cited by this paper
• Monitoring the ubiquitin/proteasome system in conformational diseases.

  2003cited by this paper
• Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase.

  2003cited by this paper
• In vivo half-life of a protein is a function of its amino-terminal residue.

  1986cited by this paper
• Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

  1983cited by this paper

• Small molecule proteasome activation: comparative structural analysis of known stimulators.

  2025cites this paper
• A luminescence-based biosensor to measure endogenous UBE3A activity

  2025cites this paper
• Bisphenol-A (BPA) Impairs Hippocampal Neurogenesis via Inhibiting Regulation of the Ubiquitin Proteasomal System

  2023cites this paper
• Incorporating a β-hairpin sequence motif to increase intracellular stability of a peptide-based PROTAC.

  2023cites this paper
• Targeted protein degradation in mammalian cells: A promising avenue toward future

  2022cites this paper
• Two novel piperidones induce apoptosis and antiproliferative effects on human prostate and lymphoma cancer cell lines

  2022cites this paper
• A technology of a different sort: microraft arrays.

  2021cites this paper
• Hallmarks and detection techniques of cellular senescence and cellular ageing in immune cells

  2021cites this paper
• Endoplasmic reticulum stress: an arising target for metal-based anticancer agents.

  2020cites this paper
• A hysteretic genetic circuit for detection of proteasomal degradation in mammalian cells.

  2019cites this paper
• Direct measurement of deubiquitinating enzyme activity in intact cells using a protease-resistant, cell-permeable, peptide-based reporter.

  2019cites this paper
• Proteasome 26S Subunit, non-ATPase 3 (PSMD3) Regulates Breast Cancer by Stabilizing HER2 from Degradation

  2019cites this paper
• Methods to Discover and Evaluate Proteasome Small Molecule Stimulators

  2019cites this paper
• Nanoreactors: Strategies to encapsulate enzyme biocatalysts in virus-like particles.

  2018cites this paper
• Determining xE2-xE3 Pair of RNF38 by Phage Display for Orthogonal Ubiquitin Transfer

  2018cites this paper
• Development of β-Hairpin Peptides for the Measurement of SCF-Family E3 Ligase Activity in Vitro via Ornithine Ubiquitination

  2017cites this paper
• UbFluor: a mechanism-based probe for HECT E3 ligases

  2016cites this paper
• Target and resistance-related proteins of recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand on myeloma cell lines.

  2016cites this paper
• Development of two novel high-throughput assays to quantify ubiquitylated proteins in cell lysates: application to screening of new anti-malarials

  2015cites this paper
• Expression of HERC4 in lung cancer and its correlation with clinicopathological parameters.

  2015cites this paper
• Development of Protease-Resistant β-Hairpin Peptides for the Detection of Enzymatic Activity in Cancer Cells

  2014cites this paper
• Mechanisms of Astrocyte Contribution to Bortezomib-Induced Peripheral Neuropathy

  2014cites this paper
• A Comparative Analysis of the Ubiquitination Kinetics of Multiple Degrons to Identify an Ideal Targeting Sequence for a Proteasome Reporter

  2013cites this paper
• Ubiquitin-Proteasome Pathway and Prostate Cancer

  2013cites this paper